Neuropace Inc (NPCE) — 10-Q Filings
All 10-Q filings from Neuropace Inc. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
NeuroPace Revenue Jumps 30% Amidst Strategic Equity Moves
— Nov 4, 2025 Risk: medium
NeuroPace Inc. (NPCE) reported a significant increase in revenue for the three months ended September 30, 2025, reaching $27.35 million, up from $21.06 million -
NeuroPace Revenue Jumps 19.6% in Q2, Net Loss Narrows Slightly
— Aug 12, 2025 Risk: high
NeuroPace Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $16.5 million, up from $13.8 million in the prior-y -
NeuroPace Inc. Files Q2 2024 10-Q Financial Report
— Aug 13, 2024 Risk: medium
NeuroPace Inc. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The filing details its fiscal year end as December 31
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX